For the Inventor, By the Inventor

Enter assignee name

Abano Terme, Italy

Fidia Farmaceutici S.p.a.

USPTO Granted Patents = 84

CIPO Patents = 17

EPO Patents = 67

Trademarks = 50

Forward Citations = 238

Loading Chart...

Loading Chart...

100 inventors (with patents filed for the assignee):

Giovanni Gennari (20 out of 21 patents)

Susanna Vaccaro (16 out of 17 patents)

Anna Maria Zanellato (14 out of 14 patents)

4. Davide Renier (10 out of 13 patents)

5. Lanfranco Callegaro (10 out of 60 patents)

6. Vincenza Corsa (9 out of 9 patents)

7. Luciano Messina (9 out of 9 patents)

8. Devis Galesso (8 out of 8 patents)

9. Monica Campisi (8 out of 8 patents)

10. Davide Bellini (7 out of 15 patents)

11. Matteo D'Este (6 out of 6 patents)

12. Salvatore Caruso (4 out of 4 patents)

13. Cristian Guarise (4 out of 4 patents)

14. Alessandro Negro (4 out of 6 patents)

15. Mara Pittarello (3 out of 3 patents)

Core Competencies:

Hyaluronic Acid

Controlled Release Systems

Nanosystems

Pharmaceutical Compositions

Dermal Therapeutics

Collagenase Enzyme

Antitumoral Bioconjugates

Wound Healing

3D Printing

Sulfated Hyaluronic Acids

Composite Materials

Biological Materials

84 patents: Sort by Forward Citations

1. 12465649 - Paclitaxel-hyaluronic acid conjugate in the treatment of non-muscle invasive bladder cancer (2025-11-11),

2. 12465596 - Stabilisation and controlled-release systems for medicaments unstable on sterilisation (2025-11-11),

3. 12447134 - Multilayer composite material (2025-10-21),

4. 12403646 - Method for 3D printing with a bio-ink (2025-09-02),

5. 12364784 - Wound dressing for treatment of damaged skin (2025-07-22),

6. 12310942 - Pharmaceutical compositions comprising statins and hyaluronic acid derivatives (2025-05-27),

7. 12251416 - Pharmaceutical compositions containing hyaluronic acid and carnosine and relative use (2025-03-18),

8. 12135262 - Comminuting device of biological material and relative method for comminuting and cellular preparations (2024-11-05),

9. 12115229 - Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes (2024-10-15),

10. 11684588 - Multilayer composite material (2023-06-27),

11. 11613743 - Process for the production and purification of the collagenase enzyme from (2023-03-28),

12. 11510995 - Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes (2022-11-29),

13. 11395833 - Process for the preparation and purification of the sodium salt of hyaluronic acid (2022-07-26),

14. 11357858 - Pharmaceutical compositions for the treatment of postoperative pain (2022-06-14),

15. 11241484 - Pharmaceutical compositions comprising collagen and sodium hyaluronate (2022-02-08),

Fidia Farmaceutici S.p.A. is an Italian pharmaceutical company that specializes in the research, development, and production of innovative healthcare solutions. With a focus on areas such as orthopedics, hyaluronic acid-based products, and tissue regeneration, Fidia aims to improve patients' lives and well-being. Through its advanced scientific methods and commitment to excellence, Fidia has established itself as a key player in the global pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

84 Patents

#1 in Abano Terme

#108 in Italy

#8,743 in the World

Abano Terme, Italy

Fidia Farmaceutici S.p.a.

Forward Citations = 238

100 inventors:

Giovanni Gennari (20 out of 21 patents)

Susanna Vaccaro (16 out of 17 patents)

Anna Maria Zanellato (14 out of 14 patents)

4. Davide Renier (10 out of 13 patents)

5. Lanfranco Callegaro (10 out of 60 patents)

Please report any incorrect information to support@idiyas.com

Loading…